Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
At least 19 states are directing money from Medicaid into housing aid and addressing the nation’s growing homelessness epidemic.
Drug use and homelessness were among the top reported risk factors during the 2016 to 2022 hepatitis A outbreak.
New policy will enable doctors and nurses to offer street medicine to homeless people.
Offering hepatitis C treatment at the point of diagnosis streamlines care, saving both time and money.
A boost in protection is needed to offset the persistent disparities in the toll of COVID between racial and ethnic groups.
Hepatitis A and B declined in 2021, but new hepatitis C cases have doubled since 2014.
Recent drug use along with unstable housing increased the risk of acquiring HCV again.
The pilot program focuses on vulnerable patients with limited access to tests and treatment.
Most hepatitis A infections in recent years have been seen in people who use drugs and people experiencing homelessness.
Pairing HCV testing and treatment eliminates the need to navigate the medical system.
Unstable housing is also associated with a higher HIV viral load.
Low-barrier care and access to multiple services in one place can improve outcomes for people experiencing homelessness or unstable housing.
Assessing patient-reported outcomes can support treatment for hard-to-reach populations.
Health officials remain concerned about HIV and hepatitis C transmissions during COVID-19.
Formerly a homeless person who used heroin, she advocated for New Yorkers affected by housing insecurity, drugs, HIV and hepatitis.
Homeless people, incarcerated individuals and people with mental health conditions achieved a high cure rate.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.